The Savvy Diabetic Research Update: 9 March 2016
Senseonics’ Eversense: 90-day Implanted CGM Enters US Pivotal Trial www.DiaTribe.org, 2/26/2016 This pivotal trial will evaluate the accuracy and safety of the Senseonics’ implantable, 90-day Eversense CGM system. Eversense CGM measurements will be compared to a...
Insulin-producing Mini Stomachs a Possible Diabetes Treatment
This is an exciting bit of news from the Harvard Stem Cell Institute, as reported in Gizmag magazine, 22 February 2016. At the bottom is the link to the original research article published in Cell Stem Cell. Patients with Type 1 diabetes suffer from an absence of...
Take a Survey on the DiabetesMine Challenge Matrix
DiabetesMine is developing a new tool to help the diabetes patient community provide feedback on the tools and services available to us now. The idea is to allow the community to rate everything – from BG measuring devices to apps to nutrition and coaching programs –...
Research Update: Kidney Pill, New App, Stem Cell News
Finerenone, undergoing 2 clinical trials for safety and efficacy, is a new medication developed by Bayer that may help reduce markets of kidney malfunction called “proteinuria” (the presence of abnormal quantities of protein in the urine). Read more on DiaTribe.org:...
About Gut Bacteria and Diabetes
I find this area of research so very interesting … and can hardly wait til we learn more. According to Ginger Vieira of DiabetesDaily (www.diabetesdaily.com), Type 1 and Type 2 diabetes may be linked to the bacteria in your gut. What we eat impacts every part...
More Diabetes Blogs